We are live on ! Find out more
GNPX icon

Genprex

8 hedge funds and large institutions have $510K invested in Genprex in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more capital invested

Capital invested by funds: $426K → $510K (+$84.3K)

0% more funds holding

Funds holding: 88 (0)

0% more ownership

Funds ownership: 0.01%0.01% (+0%)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

Holders
8
Holders Change
Holders Change %
0%
% of All Funds
0.12%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
3
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change

GNPX Hedge Fund Activity: Q2 2024 in Review

8 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Genprex (GNPX) for Q2 2024, worth a combined $510K — up 20% from $426K a quarter earlier.

Fund positioning in GNPX was balanced in Q2 2024: 1 fund opened new positions, 1 closed out, 3 added to existing stakes and 0 trimmed.

The largest buyer was Armistice Capital, adding an estimated $293K. The largest seller was UBS Group, exiting entirely with an estimated $2.69K sold.

  • 8 institutional investors held Genprex (GNPX) as of Q2 2024, unchanged from Q1 2024.
  • Funds reported $510K of Genprex stock for Q2 2024, up 20% quarter-over-quarter.
  • 1 fund opened new Genprex positions in Q2 2024 and 1 closed out, a net change of 0 holders.
  • The largest Genprex buyer in Q2 2024 was Armistice Capital, an estimated $293K added.
  • The largest Genprex seller in Q2 2024 was UBS Group, an estimated $2.69K sold.

Based on aggregated 13F filings for Q2 2024.